Skip to main content
logo
Novakand Pharma AB (publ) (STO:NOVKAN)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0250
-0.0196 (-43.95%)
Inactive · Last trade price on Apr 13, 2026

Novakand Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
319133370169344
Market Cap Growth
-97.88%-85.70%-64.21%119.29%-50.92%-51.68%
Enterprise Value
-13-375312101226
Last Close Price
0.030.161.094.442.085.99

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.201.262.137.771.582.81
P/TBV Ratio
0.201.262.9912.491.973.39

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-----0.01
Net Debt / Equity Ratio
-1.07-1.07-0.74-0.96-0.89-0.86
Net Debt / EBITDA Ratio
--1.070.721.822.27
Net Debt / FCF Ratio
0.530.530.790.822.002.40
Quick Ratio
9.899.8910.392.616.9410.72
Current Ratio
10.0310.0310.612.657.2010.72
Return on Equity (ROE)
-122.09%-122.09%-81.05%-83.96%-45.75%-46.90%
Return on Assets (ROA)
-44.23%-44.23%-43.53%-44.32%-25.91%-27.11%
Return on Capital Employed (ROCE)
-196.50%-196.50%-74.10%-138.60%-49.30%-38.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1558.89%-249.18%-33.62%-17.52%-31.07%-13.28%
FCF Yield
--159.81%-44.15%-15.03%-28.16%-12.82%
Buyback Yield / Dilution
-5.08%-5.08%-44.85%-36.90%-3.91%-54.18%